Chengdu New Radiomedicine Technology Co. LTD.
4 clinical trials · Sponsor
◉ Watch Chengdu New Radiomedicine Technology Co. LTD.
| Record | Firm | Date |
|---|---|---|
| Safety Trial of 68Ga/177Lu-NRT6020 in FAP-Positive Advanced Solid Tumor Patients (NCT06911489) | Chengdu New Radiomedicine Technology Co. LTD. | 2025-11-29 |
| Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere (NCT06900543) | Chengdu New Radiomedicine Technology Co. LTD. | 2025-04-15 |
| Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases (NCT06278454) | Chengdu New Radiomedicine Technology Co. LTD. | 2024-01-09 |
| Safety and Efficacy of TareSphere in Patients With Unresectable Hepatocellular Carcinoma (NCT06310590) | Chengdu New Radiomedicine Technology Co. LTD. | 2023-08-08 |
Track Chengdu New Radiomedicine Technology Co. LTD. automatically
Every clearance here is in the API, with alerts when new ones post.